Picture of Lunit logo

328130 Lunit Share Price

0.000.00%
kr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMid CapNeutral

Momentum

Relative Strength (%)
1m-10.01%
3m-31.42%
6m-12.36%
1yr+241.66%
Volume Change (%)
10d/3m+46.79%
Price vs... (%)
52w High-48.5%
50d MA-7.49%
200d MA-8.68%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)n/a
PEG Ratio (f)n/a
EPS Growth (f)n/a
Dividend Yield (f)n/a
Valuation (ttm)IndustryMarket
Price to Book Value39.93
Price to Tang. Book41.34
Price to Free Cashflown/a
Price to Sales81.92
EV to EBITDAn/a

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-55.91%
Return on Equity-59.47%
Operating Margin-161.46%

Financial Summary

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202331st Dec 2024
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2023 / 2024

Blurred out image of Lunit EPS forecast chart

Profile Summary

Lunit Inc is a Korea-based company principally engaged in the development and supply of medical software. The Company is principally engaged in the development and supply of medical software such as cancer diagnostic aid solutions, cancer early detection solutions, cancer risk prediction solutions and others through artificial intelligence (AI) technologies.

Directors

    Last Annual
    December 31st, 2022
    Last Interim
    September 30th, 2023
    Incorporated
    August 23rd, 2013
    Public Since
    July 21st, 2022
    No. of Employees
    293
    Sector
    Healthcare Equipment & Supplies
    Industry
    Healthcare
    Exchange
    kr flag iconKorea Exchange - KOSDAQ
    Shares in Issue
    28,759,810

    328130 Share Price Performance

    Similar to 328130

    Picture of Access Bio logo

    Access Bio

    kr flag iconKorea Exchange - KOSDAQ

    Picture of Aligned Genetics logo

    Aligned Genetics

    kr flag iconKorea Exchange - KOSDAQ

    Picture of Asta Co logo

    Asta Co

    kr flag iconKorea Exchange - KOSDAQ

    Picture of Biodyne Co logo

    Biodyne Co

    kr flag iconKorea Exchange - KOSDAQ

    Picture of Bistos Co logo

    Bistos Co

    kr flag iconKorea Exchange - KOSDAQ

    FAQ